Opus Genetics, Inc. (IRD) Stock Overview
Explore Opus Genetics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Opus Genetics, Inc. (IRD)
Key Financials
Key Financials
Market Cap
328M
P/E Ratio
-36.65
EPS (TTM)
$-1.31
ROE
60.69%
IRD Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Opus Genetics, Inc. (IRD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 41.37, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.86.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -36.65 and a market capitalization of 328M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.